Swim club: Expensive male fertility supplements are all the rage

SwimClub, a new male fertility-supplement company, markets to both men and women. “You can’t out-ovulate bad sperm,” reads one ad. “Don’t leave conception to chance,” reads another.

Osman Khan, SwimClub’s co-founder, said he’d discovered he had a low sperm count amid a failed round of IVF. … With the help of his wife, he assembled his own supplement stack. His sperm-metrics improved, and he and his wife successfully had a baby via IVF.

The experience led him and two business partners to work with urologist Dr. Michael Eisenberg, director of the Male Reproductive Medicine and Surgery program at Stanford University, to build a supplement pack they could sell. … For roughly $300, men receive a 90-day supply of daily pills.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

Venture capitalists poured $121 million in funding into startups focused on male fertility last year, according to data from PitchBook. …

 “I’m getting more patients asking about supplements …,” said Dr. Bobby Najari, director of NYU Langone’s male-infertility program. But he doesn’t routinely recommend male prenatals, he said, citing limited studies for men, unlike for women, as well as challenges deciphering between brands in an industry not vigorously regulated.

This is an excerpt. Read the original post here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-04-22-at-12.21.32-PM
Viewpoint: Why the retracted Monsanto glyphosate study doesn’t change the science—the world’s most popular herbicide is safe 
Picture1
The FDA couldn’t find a vaccine safety crisis, so it buried its own research
ChatGPT-Image-May-1-2026-11_42_59-AM-2
Viewpoint: NAD is the wellness grifters latest evidence-lite longevity fad. At least the mice are impressed.
global warming
‘Implausible’: Top climate scientists reject worst-case scenario—soaring temperatures and fast-rising sea levels
ChatGPT-Image-Apr-16-2026-02_56_53-PM
Financial incentives, over diagnosis, and weak oversight: Autism claims are driving up Medicare costs
vax-misinformation-main
Facts & Fallacies Podcast: Limit free speech to blunt social media misinfo?
Screenshot-2026-05-21-at-12.15.17-PM
UK gene-editing milestone: Livestock barley that increases ruminant value and reduces methane emissions is first-approved CRISPR crop
Screenshot-2026-05-21-at-3.15.53-PM
Chiropractors may no longer be modern-day snake oil salesmen, but the benefits of their therapy are limited–at best
ChatGPT-Image-May-12-2026-11_27_01-AM-2
AI likely to improve health care, research shows—but not for blacks and ethnic minorities
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.